Metric Deep Dive: Understanding Calumet Inc (CLMT) Through its Ratios

Kiel Thompson

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

After finishing at $19.15 in the prior trading day, Calumet Inc (NASDAQ: CLMT) closed at $19.28, up 0.68%. In other words, the price has increased by $0.68 from its previous closing price. On the day, 0.58 million shares were traded. CLMT stock price reached its highest trading level at $19.725 during the session, while it also had its lowest trading level at $19.04.

Ratios:

Our goal is to gain a better understanding of CLMT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 1.13.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, TD Cowen on Nov-12-25, Reiterated its Hold rating but revised its target price to $18 from $15 previously.

On May 13, 2025, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.

UBS Upgraded its Sell to Neutral on March 17, 2025, whereas the target price for the stock was revised from $15 to $12.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when DANIEL J SAJKOWSKI 2011 TRUST bought 2,000 shares for $15.76 per share.

Morical Gregory J sold 25,123 shares of CLMT for $419,303 on Jun 16 ’25. The SVP, GENERAL COUNSEL now owns 39,415 shares after completing the transaction at $16.69 per share. On Jun 16 ’25, another insider, Straumins Jennifer, who serves as the Director of the company, sold 100,000 shares for $16.23 each. As a result, the insider received 1,623,000 and left with 934,589 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLMT now has a Market Capitalization of 1672623360 and an Enterprise Value of 4126182912. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41. Its current Enterprise Value per Revenue stands at 1.019 whereas that against EBITDA is 11.809.

Stock Price History:

The Beta on a monthly basis for CLMT is 1.18, which has changed by -0.037688434 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, CLMT has reached a high of $23.75, while it has fallen to a 52-week low of $7.68. The 50-Day Moving Average of the stock is 3.29%, while the 200-Day Moving Average is calculated to be 26.62%.

Shares Statistics:

The stock has traded on average 836.07K shares per day over the past 3-months and 887490 shares per day over the last 10 days, according to various share statistics. A total of 86.75M shares are outstanding, with a floating share count of 67.26M. Insiders hold about 22.47% of the company’s shares, while institutions hold 51.37% stake in the company. Shares short for CLMT as of 1761868800 were 8002271 with a Short Ratio of 9.78, compared to 1759190400 on 8516040. Therefore, it implies a Short% of Shares Outstanding of 8002271 and a Short% of Float of 11.67.

Earnings Estimates

The dynamic stock of Calumet Inc (CLMT) is currently attracting attention from 1.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.01, with high estimates of $0.01 and low estimates of $0.01.

Analysts are recommending an EPS of between -$1.76 and -$1.76 for the fiscal current year, implying an average EPS of -$1.76. EPS for the following year is $0.41, with 1.0 analysts recommending between $0.41 and $0.41.

Revenue Estimates

5 analysts predict $1.02B in revenue for. The current quarter. It ranges from a high estimate of $1.18B to a low estimate of $798.2M. As of. The current estimate, Calumet Inc’s year-ago sales were $949.5MFor the next quarter, 5 analysts are estimating revenue of $1.04B. There is a high estimate of $1.12B for the next quarter, whereas the lowest estimate is $899.4M.

A total of 5 analysts have provided revenue estimates for CLMT’s current fiscal year. The highest revenue estimate was $4.28B, while the lowest revenue estimate was $3.9B, resulting in an average revenue estimate of $4.09B. In the same quarter a year ago, actual revenue was $4.19BBased on 6 analysts’ estimates, the company’s revenue will be $4.26B in the next fiscal year. The high estimate is $5.05B and the low estimate is $3.22B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.